<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <Volume-Issue>Volume 4; Issue 4 </Volume-Issue>
      <Season>(Jul-Aug, 2023)</Season>
      <ArticleType>Medical Case Reports</ArticleType>
      <ArticleTitle>CRISPR/Cas9-Based Imaging: Challenges and Future Prospects</ArticleTitle>
      <Abstract>In 1987, CRISPR (clustered regularly interspaced short palindromic repeats), was discovered in the Escherichia coli genome. It is a component of the adaptive immune system in prokaryotic, archaeal, and bacterial organisms. since it was discovered in bacteria, understanding CRISPR structure and function has made it a powerful gene editing tool that used in gene therapy and diagnostics purpose. Imaging is another application of CRISPR that is also used by researchers for diagnostic purposes. This short communication aims to discuss the CRISPR imaging field and the challenges facing it.</Abstract>
      <Keywords>CRISPR,Imaging,d Cas9,gRNA</Keywords>
        <Abstract>https://jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=14764&amp;title=CRISPR/Cas9-Based Imaging: Challenges and Future Prospects</Abstract>
        <References>Anliker B, Childs L, Rau J, Renner M, Schand;uuml;le S, Schuessler-Lenz M, et al. Regulatory considerations for clinical trial applications with CRISPR-based medicinal products. The CRISPR Journal 2022; 5: 364-376.&#13;
Chaudhary N, Im JK, Nho SH, Kim H. Visualizing Live Chromatin Dynamics through CRISPR-Based Imaging Techniques. Mol Cells 2021; 44: 627-636.&#13;
Choi E, Koo T. CRISPR technologies for the treatment of Duchenne muscular dystrophy. Molecular Therapy 2021; 29: 3179-3191.&#13;
Kim S, Ji S, Koh HR. CRISPR as a Diagnostic Tool. Biomolecules 2021; 11: 1162.&#13;
LaFleur MW, Nguyen TH, Coxe MA, Yates KB, Trombley JD, Weiss SA, Brown FD, Gillis JE, Coxe DJ, Doench JG, Haining WN. A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system. Nat commun 2019; 10: 1668.&#13;
Liu G, Lin Q, Jin S, Gao C. The CRISPR-Cas toolbox and gene editing technologies. Molecular cell 2021.&#13;
Lucansky V, Holubekova V, Kolkova Z, Halasova E, Samec M, Golubnitschaja O. Multi-faceted CRISPR/Cas technological innovation aspects in the framework of 3P medicine. EPMA J 2023; 22: 1-7.&#13;
Lyu XY, Deng Y, Huang XY, Li ZZ, Fang GQ, Yang D, Wang FL, Kang W, Shen EZ, Song CQ. CRISPR FISHer enables high-sensitivity imaging of nonrepetitive DNA in living cells through phase separation-mediated signal amplification. Cell Res 2022; 32: 969-981.&#13;
Mao S, Ying Y, Wu X, Krueger CJ, Chen AK. CRISPR/dual-FRET molecular beacon for sensitive live-cell imaging of non-repetitive genomic loci. Nucleic Acids Res 2019; 47: e131-e31.&#13;
Rheney J. Using Crisper in the Treatment of Sickle Cell Disease. J Stud Res 2023; 12.&#13;
Selvaraj D, Dawar R, Sivakumar PK, Devi A. Clustered regularly interspaced short palindromic repeats, a glimpse–impacts in molecular biology, trends and highlights. Horm Mol Biol Clin Investig 2021; 28: 105-112.&#13;
Tang N, Cheng C, Zhang X, Qiao M, Li N, Mu W, Wei XF, Han W, Wang H. TGF-and;beta; inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors. JCI Insight 2020; 5: e133977.&#13;
Thuma J, Chung YC, Tu LC. Advances and challenges in CRISPR-based real-time imaging of dynamic genome organization. Front in Mol Biosci 2023; 10: 1173545.&#13;
Vuelta E, Garcia-Tunon I, Hernandez-Carabias P, Mendez L, Sanchez-Martin M. Future approaches for treating chronic myeloid leukemia: CRISPR therapy. Biology 2021; 10: 118.&#13;
Wang SW, Gao C, Zheng YM, Yi L, Lu JC, Huang XY, Cai JB, Zhang PF, Cui YH, Ke AW. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer. Mol cancer 2022; 21: 1-27.&#13;
Wu X, Mao S, Ying Y, Krueger CJ, Chen AK. Progress and challenges for live-cell imaging of genomic loci using CRISPR-based platforms. Int J Genomics Proteomics 2019; 17: 119-128.</References>